Fed. Circ. Affirms Invalidity Of Bayer's Yasmin Patent
A federal appeals court has upheld a ruling that invalidated the patent for Bayer Schering Pharma AG's oral contraceptive Yasmin in a dispute with Barr Laboratories Inc. over a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article